日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recombinant Human SLPI Surface Functionalization Enhances Early Osseointegration and Biomechanical Stability of Titanium Implants in Rat Model

重组人SLPI表面功能化增强大鼠模型中钛种植体的早期骨整合和生物力学稳定性

Chouyratchakarn, Wannapat; Boonsri, Burin; Tangkamonsri, Surasak; Thepsupa, Watchara; Supanchart, Chayarop; Kumphune, Sarawut

The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications

分泌型白细胞蛋白酶抑制剂(SLPI)在非传染性疾病病理生理学中的作用:从实验研究到临床应用的证据

Mongkolpathumrat, Podsawee; Pikwong, Faprathan; Phutiyothin, Chayanisa; Srisopar, Onnicha; Chouyratchakarn, Wannapat; Unnajak, Sasimanas; Nernpermpisooth, Nitirut; Kumphune, Sarawut

Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation

重组人分泌性白细胞蛋白酶抑制剂(rhSLPI)涂覆钛增强人成骨细胞粘附和分化

Radchanon Leelasukseree, Wannapat Chouyratchakarn, Chayanisa Phutiyothin, Faprathan Pikwong, Onnicha Srisopar, Phornsawat Baipaywad, Suruk Udomsom, Podsawee Mongkolpathumrat, Chayarop Supanchart, Sarawut Kumphune

Gelatin-coated silicon oxide nanoparticles encapsulated recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced cardiac cell death against an in vitro simulated ischaemia/reperfusion injury

明胶包覆的氧化硅纳米粒子包裹的重组人分泌性白细胞蛋白酶抑制剂 (rhSLPI) 可减少体外模拟缺血/再灌注损伤中的心脏细胞死亡

Faprathan Pikwong, Chayanisa Phutiyothin, Wannapat Chouyratchakarn, Phornsawat Baipaywad, Podsawee Mongkolpathumrat, Sarawut Kumphune

Adeno-associated virus 9 vector-mediated cardiac-selective expression of human secretory leukocyte protease inhibitor attenuates myocardial ischemia/reperfusion injury

腺相关病毒 9 载体介导的人类分泌性白细胞蛋白酶抑制剂的心脏选择性表达可减轻心肌缺血/再灌注损伤

Podsawee Mongkolpathumrat, Nitirut Nernpermpisooth, Anusak Kijtawornrat, Faprathan Pikwong, Wannapat Chouyratchakarn, Rungrueang Yodsheewan, Sasimanas Unajak, Sarawut Kumphune